Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R21 CA223140
National Institutes of Health
Grant: 5P30DK056338-18
Texas Medical Center Digestive Diseases Center
European Commission
Grant: 826121
individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology
National Institutes of Health
Grant: 5R21CA223140-02
Diagnostic biomarkers for hepatoblastomas with hepatocellular carcinoma features
Fields of Study
Keywords